Riluzole likely lacks antidepressant efficacy in ketamine non-responders

被引：16

作者：

Niciu, Mark J. ^{[1
]}

Luckenbaugh, David A. ^{[1
]}

Ionescu, Dawn F. ^{[1
]}

Richards, Erica M. ^{[1
]}

Voort, Jennifer L. Vande ^{[1
]}

Ballard, Elizabeth D. ^{[1
]}

Brutsche, Nancy E. ^{[1
]}

Furey, Maura L. ^{[1
]}

Zarate, Carlos A., Jr. ^{[1
]}

机构：

[1] NIMH, ETPB, NIH, Bethesda, MD 20892 USA

来源：

JOURNAL OF PSYCHIATRIC RESEARCH | 2014年 / 58卷

关键词：

Major depressive disorder; Treatment-resistant depression; Ketamine; Riluzole; Glutamate; OPEN-LABEL TRIAL; DEPRESSIVE SYMPTOMS;

D O I：

10.1016/j.jpsychires.2014.07.022

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

页码：197 / 199

页数：3

共 10 条

[1] Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole [J].

Banasr, M. ;

Chowdhury, G. M. I. ;

Terwilliger, R. ;

Newton, S. S. ;

Duman, R. S. ;

Behar, K. L. ;

Sanacora, G. .

MOLECULAR PSYCHIATRY, 2010, 15 (05) :501-511

[2] Course of Improvement in Depressive Symptoms to a Single Intravenous Infusion of Ketamine vs Add-on Riluzole: Results from a 4-Week, Double-Blind, Placebo-Controlled Study [J].

Ibrahim, Lobna ;

DiazGranados, Nancy ;

Franco-Chaves, Jose ;

Brutsche, Nancy ;

Henter, Ioline D. ;

Kronstein, Phillip ;

Moaddel, Ruin ;

Wainer, Irving ;

Luckenbaugh, David A. ;

Manji, Husseini K. ;

Zarate, Carlos A., Jr. .

NEUROPSYCHOPHARMACOLOGY, 2012, 37 (06) :1526-1533

[3] Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial [J].

Mathew, Sanjay J. ;

Murrough, James W. ;

aan het Rot, Marije ;

Collins, Katherine A. ;

Reich, David L. ;

Charney, Dennis S. .

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 (01) :71-82

[4] NEW DEPRESSION SCALE DESIGNED TO BE SENSITIVE TO CHANGE [J].

MONTGOMERY, SA ;

ASBERG, M .

BRITISH JOURNAL OF PSYCHIATRY, 1979, 134 (APR) :382-389

[5] Glutamate Receptor Antagonists as Fast-Acting Therapeutic Alternatives for the Treatment of Depression: Ketamine and Other Compounds [J].

Niciu, Mark J. ;

Henter, Ioline D. ;

Luckenbaugh, David A. ;

Zarate, Carlos A., Jr. ;

Charney, Dennis S. .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54, 2014, 54 :119-139

[6] Overview of glutamatergic neurotransmission in the nervous system [J].

Niciu, Mark J. ;

Kelmendi, Benjamin ;

Sanacora, Gerard .

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2012, 100 (04) :656-664

[7] Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms [J].

Sanacora, Gerard ;

Kendell, Steven F. ;

Levin, Yael ;

Simen, Arthur A. ;

Fenton, Lisa R. ;

Coric, Vladimir ;

Krystal, John H. .

BIOLOGICAL PSYCHIATRY, 2007, 61 (06) :822-825

[8] Therapeutic Options for Treatment-Resistant Depression [J].

Shelton, Richard C. ;

Osuntokun, Olawale ;

Heinloth, Alexandra N. ;

Corya, Sara A. .

CNS DRUGS, 2010, 24 (02) :131-161

[9] An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression [J].

Zarate, CA ;

Quiroz, JA ;

Singh, JB ;

Denicoff, KD ;

De Jesus, G ;

Luckenbaugh, DA ;

Charney, DS ;

Manji, HK .

BIOLOGICAL PSYCHIATRY, 2005, 57 (04) :430-432

[10] An open-label trial of riluzole in patients with treatment-resistant major depression [J].

Zarate, CA ;

Payne, JL ;

Quiroz, J ;

Sporn, J ;

Denicoff, KK ;

Luckenbaugh, D ;

Charney, DS ;

Manji, HK .

AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (01) :171-174

← 1 →